Nucleic acid therapeutics have significant potential to address diseases that historically have been challenging to treat with small molecule drugs or biologics.

Our unique chemistry platform opens up a world of potential, overcoming some of the historical challenges of oligonucleotide approaches to address a broad range of serious diseases. This fully integrated approach spanning discovery, manufacturing, supply and patient support creates a transformational, long-term platform beyond any one program.